Capital Financial Services’s AbbVie ABBV Stock Holding History

Capital Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1M	Sell	6,210 -215	-3%	-$33K	1.38%	26
2022 Q3	$862K	Sell	6,425 -10	-0.2%	-$1.44K	1.27%	27
2022 Q2	$986K	Hold	6,435	–	–	1.39%	27
2022 Q1	$1.04M	Hold	6,435	–	–	1.23%	31
2021 Q4	$871K	Hold	6,435	–	–	0.95%	36
2021 Q3	$694K	Buy	6,435 +225	+4%	+$25.7K	0.85%	40
2021 Q2	$699K	Sell	6,210 -80	-1%	-$9.01K	0.89%	38
2021 Q1	$681K	Hold	6,290	–	–	0.91%	39
2020 Q4	$674K	Buy	+6,290	New	+$604K	0.94%	37

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Financial Services's ABBV Position: Q4 2022 in Review

Capital Financial Services reduced its AbbVie (ABBV) stake by 3.3% in Q4 2022, selling an estimated $33K and leaving 6,210 shares worth $1M. The position accounts for 1.38% of the portfolio, ranked #26.

Capital Financial Services first reported a position in ABBV in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.04M in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Capital Financial Services held 6,210 shares of AbbVie worth $1M as of Q4 2022.
Capital Financial Services sold 215 AbbVie shares in Q4 2022, an estimated $33K.
AbbVie made up 1.38% of Capital Financial Services's portfolio in Q4 2022, its #26 holding.
Capital Financial Services first reported a position in AbbVie in Q4 2020 and has held it in 9 quarters since.
Capital Financial Services's AbbVie position peaked at $1.04M in Q1 2022.
3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.